Premium
Prolonged‐release budesonide for mild‐to‐moderate ulcerative colitis
Author(s) -
Chaplin Steve,
DigbyBell Jonathan
Publication year - 2015
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1416
Subject(s) - budesonide , ulcerative colitis , medicine , mmx , gastroenterology , colitis , corticosteroid , disease , computer science , operating system
Cortiment is a new multimatrix (MMX) prolonged‐release formulation of budesonide for the treatment of mild‐to‐moderate active ulcerative colitis, which releases budesonide at a controlled rate throughout the colon. Here, Steve Chaplin outlines the clinical trial data for its efficacy and Jonathan Digby‐Bell discusses its place in therapy.